Comparative effectiveness of an angiotensin receptor blocker, olmesartan medoxomil, in older hypertensive patients

E-ISSN： 1751-7176|20|2|356-365

ISSN： 1524-6175

Source： The Journal of Clinical Hypertension, Vol.20, Iss.2, 2018-02, pp. : 356-365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin‐Converting Enzyme Inhibitors: The Prospective EARLY Registry

The Journal of Clinical Hypertension, Vol. 17, Iss. 12, 2015-12 ,pp. : 947-953

John Wiley & Sons Inc

Access to resources Recommend Favorite

Enhanced Blood Pressure–Lowering Effect of Olmesartan in Hypertensive Patients With Chronic Kidney Disease–Associated Sympathetic Hyperactivity: HONEST Study

The Journal of Clinical Hypertension, Vol. 15, Iss. 8, 2013-08 ,pp. : 555-561

John Wiley & Sons Inc

Access to resources Recommend Favorite

Associations of Angiotensin‐Converting Enzyme Insertion/Deletion, Angiotensin II Receptor A1166C, and Endothelial Nitric Oxide Synthase 4b/a Gene Polymorphisms With Pregnancy Hypertensive Disorders: A Meta‐Analysis

The Journal of Clinical Hypertension, Vol. 17, Iss. 12, 2015-12 ,pp. : 954-962

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to The Relationship Between Hypertensive Crisis and Patients Outcome

The Journal of Clinical Hypertension, Vol. 15, Iss. 8, 2013-08 ,pp. : 609-609

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double‐blind, 8‐week study

The Journal of Clinical Hypertension, Vol. 20, Iss. 1, 2018-01 ,pp. : 150-158

John Wiley & Sons Inc

Access to resources Recommend Favorite